資料載入中.....
|
請使用永久網址來引用或連結此文件:
http://ir.cmu.edu.tw/ir/handle/310903500/30532
|
| 題名: | Expression of Fas ligand in patients with evident skull base involvement of nasopharyngeal carcinoma |
| 作者: | Tsai, MH;Chow, KC;Lin, TY;Yeh, SP;Hsueh, CT;Chi, KH |
| 貢獻者: | 附設醫院醫研部;China Med Coll Hosp, Dept Med Res, Taichung 404, Taiwan;China Med Coll Hosp, Dept Otolaryngol, Taichung 404, Taiwan;China Med Coll Hosp, Hematol Oncol Sect, Dept Med, Taichung 404, Taiwan;China Med Coll, Inst Med Res, Taichung, Taiwan;Vet Gen Hosp, Ctr Canc, Taipei, Taiwan;China Med Coll Hosp, Dept Pathol, Taichung 404, Taiwan |
| 日期: | 2002 |
| 上傳時間: | 2010-09-24 14:57:10 (UTC+8) |
| 出版者: | PROFESSOR D A SPANDIDOS |
| 摘要: | The ability of technetium-99m tetrofosmin (Tc-TF) scan to predict chemotherapy response in malignant lymphomas (ML) was compared with the predictive ability of P-glycoprotein (Pgp) and multidrug resistance related protein (MRP) expression. Before chemotherapy, 25 ML patients were enrolled in this study. Scans were performed 10 min after intravenous injection of Tc-TF. Immunohistochemical analyses were performed on ML specimen sections to evaluate Pgp and MRP expression. Chemotherapy response was evaluated in the first 1-2 years after completion of chemotherapy. Based on Tc-TF scan results, the mean tumor-to-background (T/B) ratio of the 15 patients with good response (3.23 +/- 0.56) was significantly higher than that of the 10 patients with poor response (1.18 +/- 0.11). All 15 patients with good response had positive Tc-TF scan results but negative Pgp and MRP expression. All 10 patients with poor response had negative Tc-TF scan results but positive Pgp or MRP expression. No significant differences in the incidences of good and poor response results were found for patients with Hodgkin's disease versus non-Hodgkin's lymphoma, with stage I-II versus stage III-IV, with age >40 versus age less than or equal to40 years, or with B symptoms versus without B symptoms. Tc-TF scan results, which may represent either Pgp or MRP expression, accurately predict chemotherapy response in patients with ML. |
| 關聯: | ONCOLOGY REPORTS 9(2):247-251 |
| 顯示於類別: | [台中附設醫院] 期刊論文
|
在CMUR中所有的資料項目都受到原著作權保護.
|
